Medigen Vaccine Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	15,024	12,410	11,851	23,035	22,785	63,653
Market Cap Growth	7.40%	4.72%	-48.55%	1.10%	-64.20%	192.75%
Enterprise Value	13,953	11,035	10,382	21,271	20,540	62,660
Last Close Price	45.70	37.75	36.05	70.10	69.50	200.91
PE Ratio	-	-	-	-	-	45.14
Forward PE	70.31	218.70	39.19	-	-	-
PS Ratio	24.89	20.24	19.57	59.12	62.42	19.40
PB Ratio	4.27	3.57	3.08	5.99	4.53	13.61
P/TBV Ratio	4.29	3.59	3.10	6.05	4.57	13.77
P/FCF Ratio	-	-	1835.64	-	-	142.64
P/OCF Ratio	-	-	290.80	-	-	109.77
EV/Sales Ratio	23.11	18.00	17.14	54.59	56.27	19.10
EV/EBITDA Ratio	-	-	-	-	-	58.45
EV/EBIT Ratio	-	-	-	-	-	65.02
EV/FCF Ratio	-	-	1608.05	-	-	140.41
Debt / Equity Ratio	0.31	0.08	0.09	0.51	0.39	0.04
Debt / EBITDA Ratio	-	-	-	-	-	0.17
Debt / FCF Ratio	-	-	52.50	-	-	0.42
Net Debt / Equity Ratio	-0.30	-0.43	-0.41	-0.46	-0.45	-0.44
Net Debt / EBITDA Ratio	7.50	10.32	60.26	1.62	1.60	-1.91
Net Debt / FCF Ratio	6.07	14.93	-244.21	3.42	1.69	-4.59
Asset Turnover	0.13	0.15	0.12	0.06	0.06	0.75
Inventory Turnover	0.50	0.59	0.50	0.25	0.76	2.84
Quick Ratio	12.45	10.35	9.54	1.99	12.48	6.54
Current Ratio	15.32	12.77	11.94	2.21	15.38	8.48
Return on Equity (ROE)	-7.93%	-7.69%	-2.09%	-26.14%	-30.39%	36.08%
Return on Assets (ROA)	-3.66%	-4.00%	-1.74%	-11.29%	-15.18%	13.71%
Return on Capital Employed (ROCE)	-5.80%	-7.10%	-3.50%	-29.60%	-22.00%	19.80%
Earnings Yield	-1.92%	-2.27%	-0.68%	-5.04%	-6.47%	2.22%
FCF Yield	-1.18%	-0.80%	0.05%	-2.26%	-5.94%	0.70%
Buyback Yield / Dilution	-0.02%	-0.03%	-0.10%	-1.50%	-0.73%	-15.82%